Replies to post #764908 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

meirluc,

The timing really does not suggest approval being expected before then in my opinion. I think it has more to do with presenting evidence of what the next Gen trials will be looking like at a top tier academy that had their date set well ahead of time. Approval could be before or after. Obviously there would be more interest if approval comes before. Best wishes.

[learningcurve2020]

🙄. Rumor is Bosch found metal fatigue in the booth so they went with this event instead. Will be interesting to see if he takes any questions.

[kabunushi]

imo completely unconnected. NW very much needs to do a cc, not just announce "MAA was accepted" with a few extra sentences. Getting this approval alone is far from enough of an investment case. WTF is the rollout of UK commercialization? Where and when is the next licensing applcation? Plans to finance UK commercial rollout let alone any additional clinical trials on ANYTHING.

Look, they had an excuse not to say anything about commercialization rollout because they can't talk about marketing a pre-approval product. OK, I can accept that. And there is no guarantee they will do a much better job making the investment case in a way that supports a higher stock price. But it's god damn clear what they totally need to start sayiing immediately upon getting approval.

[attilathehunt]

Bottom line: Is MB's presentation suggestive of an MAA approval before June 16?

I surely hope so.

Could it also mean, L wasn't approved and now we move forward with D?

The company needs to explain more of what is going on. At least quarterly updates.